Design of the publicly available Parkinson’s disease Mendelian randomization research portal


  • A new platform was created, with Mendelian randomization analysis for 5,839 Parkinson’s disease (PD) genome-wide association studies (GWAS) and causal risk factors for PD were reported.

Why this matters

    The PD Mendelian Randomization Research Portal may serve as an evolving research tool, providing data to elucidate risk factors for PD and inform clinical trial design.